artenimol has been researched along with Carcinoma, Pancreatic Ductal in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, F; Gao, W; Huang, L; Liu, X; Sheng, W; Wang, F; Wang, Y; Ye, J; Yu, H; Zhou, H | 1 |
| Du, J; Fang, L; Hu, W; Jing, Q; Li, H; Li, Y; Ren, X; Tong, X; Wang, L; Wang, X; Wang, Y; Yang, C; Zhou, C; Zhou, Y | 1 |
2 other study(ies) available for artenimol and Carcinoma, Pancreatic Ductal
| Article | Year |
|---|---|
Redox Dyshomeostasis with Dual Stimuli-Activatable Dihydroartemisinin Nanoparticles to Potentiate Ferroptotic Therapy of Pancreatic Cancer.
Topics: Animals; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Mice; Nanoparticles; Oxidation-Reduction; Pancreatic Neoplasms | 2023 |
DHA exhibits synergistic therapeutic efficacy with cisplatin to induce ferroptosis in pancreatic ductal adenocarcinoma via modulation of iron metabolism.
Topics: Adenosine Triphosphate; Animals; Antineoplastic Combined Chemotherapy Protocols; Artemisinins; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cisplatin; DNA Damage; Drug Resistance, Neoplasm; Drug Synergism; Ferroptosis; Humans; Iron; Mice, Inbred BALB C; Mice, Nude; Mitochondria; Neoplasm Invasiveness; Pancreatic Neoplasms; Reactive Oxygen Species; Tumor Burden; Xenograft Model Antitumor Assays | 2021 |